期刊文献+

食管癌肉瘤22例临床病理分析 被引量:10

Clinicopathological analysis of esophageal carcinosarcoma:a report of 22 cases
原文传递
导出
摘要 目的探讨食管癌肉瘤(ECS)的临床病理特征和外科治疗方法。方法总结分析22例食管癌肉瘤患者的临床资料。结果本组患者术前均经食管吞钡及食管镜检查,仅有1例(4.5%)术前活检确诊为癌肉瘤。所有病例均经左胸行食管肿瘤切除,20例行主动脉弓上食管胃吻合术,2例行弓下吻合。全组病例均完成手术,无手术死亡及近、远期严重并发症。术后病检均为ECS,瘤体主要成分为肉瘤者14例,主要为癌组织者8例;12例侵及黏膜下层,10例侵达食管肌层,未见侵犯纤维膜者;淋巴结转移率18.2%(4/22);T1N0M012例,T2N0M06例,T2N1M04例。全组患者1、3、5年生存率分别为90.9%(20/22)、77.3%(17/22)、68.2%(15/22)。结论食管癌肉瘤术前确诊率低。其侵袭性不强,淋巴转移发生率较低,手术切除是主要治疗手段。 Objective To evaluate the clinicopathological characteristics and surgical treatment of esophageal carcinosarcoma. Methods The patients with esophageal carcinosarcoma were divided into two types according to barium swallow: intraluminal carcinosarcoma (n=20) and fungating carcinosarcoma (n=2). Only one esophageal carcinosarcoma case was diagnosed by esophagoscopic biopsy preoperatively. Twenty patients underwent left thoracic approach esophagectomy and esophagogastrostomy above aortic arch, and two patients underwent esophagectomy and esophagogastrostomy below aortic arch. Results All the cases-survived during operation and had no severe complication. Post-operative biopsy revealed that 21 cases had definite boundary between the carcinoma and the sarcoma. Only one case showed the invasion of carcinomatous tissues into sarcomatous tissues and mixed growth. Four cases had lymph node metastases (18.2%). The 1-, 3- and 5-year survival rates were 90.9%(20/22), 77.3% (17/22) and 68.2%(15/22) respectively. Conclusions Esophageal carcinosarcoma is a rare malignant tumor with little invasiveness, low lymph node metastasis, early clinical symptom occurrence, low preoperative accurate diagnostic rate and good prognosis. Surgical resection is the main treatment for esophageal carcinosarcoma.
出处 《中华胃肠外科杂志》 CAS 2008年第3期235-237,共3页 Chinese Journal of Gastrointestinal Surgery
关键词 食管肿瘤 癌肉瘤 诊断 外科手术 预后 Esophageal neoplasms Carcinosarcoma Diagnosis Surgical procedures, operation Prognosis
  • 相关文献

参考文献7

  • 1Zhang DW, Cheng GY, Huang GJ, et al. Operable squamous esophageal cancer: current results from the east. World J Surg, 1994,18 : 347-354.
  • 2Iwaya T, Maesawa C, Uesugi N, et al. True carcinosarcoma of the esophagus. Dis Esophagus, 2006, 19:48-52.
  • 3Nikitakis NG, Drachenberq CB, Papadimitriou JC, et al. MDM2 and CDK4 expression in carcinosareoma of the esophagus: comparison with squamous cell carcinoma and review of the literature. Exp Mol Pat, 2002,73 : 198-208.
  • 4Matsumoto T, Fujii H, Arakawa A, et al. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma. Hum Pathol, 2004,35 : 322-327.
  • 5黄健灵,罗英杰,马晋平.食管癌的治疗进展[J].中华胃肠外科杂志,2001,4(3):133-142. 被引量:2
  • 6Sasajima K, Taniguchi Y, Morino K, et al. Rapid growth of a pseudosarcoma of the esophagus. J Clin Gastroenterol, 1988, 10 : 533-536.
  • 7Sanada Y, Hihara J, Yoshida K, et al. Esophageal carcinosarcoma with intramural metastasis. Dis Esophagus, 2006, 19: 119-131.

二级参考文献109

  • 1Bosset JF,Gignoux M,Triboulet JP,et al.Chemoradiotherapy followed by surgerycompared with surgery alone in squamous-cell cancer of the esophagus.N Engl JMed,1997,337:161-167.
  • 2Coia LR,Minsky BD,John MJ,et al.The evaluation and treatment of patients receivingradiation therapy for carcinoma of the esophagus:results of the 1992-1994 Patterns of CareStudy.Cancer,1999,85:2499-2505.
  • 3Coia LR,Minsky BD,Berkey BA,et al.Outcome of patients receiving radiation forcancer of the esophagus:results of the 1992-1994 Patterns of Care Study.J ClinOncol,2000,18:455-462.
  • 4Daly JM,Fry WA,Little AG,et al.Esophageal cancer:results of an American College ofSurgeons Patient Care Evaluation Study.J Am Coll Surg,2000,190:562-572.
  • 5Law S.Chemoradiotherapy -Panacea for esophageal cancer? Commentary forchemoradiotherapy of locally advanced esophageal cancer.Long-term follow-up of aprospective randomized trial(RTOG 85-01).JAMA Southeast Asia,1999,15:9-11.
  • 6Jones DR,Parker LAJ,Detterbeck FC,et al.Inadequacy of computed tomography inassessing patients with esophageal carcinoma after inductionchemoradiotherapy.Cancer,1999,85:1026-1032.
  • 7Zuccaro G,Rice TW,Goldblum J,et al.Endoscopic ultrasound cannot determinesuitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer.AmJ Gastroenterol,1999,94:906-912.
  • 8O′ Rourke IC,McNeil RJ,Walker PJ,et al.Objective evaluation of the quality ofpalliation in patients with oesophageal cancer comparing surgery,radiotherapy andintubation.Aust N Z J Surg,1992,62:922-930.
  • 9Fink U,Stein HJ,Wilke H,et al.Multimodal treatment for squamous cell esophagealcancer.World J Surg,1995,19:198-204.
  • 10Lam KY,Law S,Ma LT,et al.Pre-operative chemotherapy for squamous cell carcinoma ofthe oesophagus:do histological assessment and p53 overexpression predictchemo-responsiveness? Eur J Cancer,1997,33:1221-1225.

共引文献1

同被引文献67

引证文献10

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部